Trial design and study setting
TreEAT is a 2-armed, open label, randomised controlled trial (1:1 allocation). Infants (between 4 and 11months of age) with IgE-mediated peanut allergy will be recruited from public and private allergy clinics in Melbourne, Australia. All study visits and procedures will be undertaken in the Melbourne Children’s Trial Centre unit of the Murdoch Children’s Research Institute based at the Royal Children’s Hospital, Melbourne, Australia.